Hasil Pencarian - Thomas W. Lycan

  • Menampilkan 1 - 6 hasil dari 6
Perbaiki Hasil
  1. 1
    A Case Report of Immune Checkpoint Inhibitor-Induced Aortitis Treated with Tocilizumab

    A Case Report of Immune Checkpoint Inhibitor-Induced Aortitis Treated with Tocilizumab oleh Chance H. Bloomer, Rahul V. Annabathula, Vanya Aggarwal, Bharathi Upadhya, Thomas W. Lycan

    Diterbitkan 2022-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    A Phase II Clinical Trial of CPI-613 in Patients with Relapsed or Refractory Small Cell Lung Carcinoma.

    A Phase II Clinical Trial of CPI-613 in Patients with Relapsed or Refractory Small Cell Lung Carcinoma. oleh Thomas W Lycan, Timothy S Pardee, William J Petty, Marcelo Bonomi, Angela Alistar, Zanetta S Lamar, Scott Isom, Michael D Chan, Antonius A Miller, Jimmy Ruiz

    Diterbitkan 2016-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Early [18]FDG PET/CT scan predicts tumor response in head and neck squamous cell cancer patients treated with erlotinib adjusted per smoking status

    Early [18]FDG PET/CT scan predicts tumor response in head and neck squamous cell cancer patients treated with erlotinib adjusted per smoking status oleh Mercedes Porosnicu, Mercedes Porosnicu, Anderson O’Brien Cox, Joshua D. Waltonen, Paul M. Bunch, Ralph D’Agostino, Ralph D’Agostino, Thomas W. Lycan, Thomas W. Lycan, Richard Taylor, Dan W. Williams, Xiaofei Chen, Kirtikar Shukla, Brian E. Kouri, Tiffany Walker, Tiffany Walker, Gregory Kucera, Gregory Kucera, Hafiz S. Patwa, Hafiz S. Patwa, Christopher A. Sullivan, Christopher A. Sullivan, J. Dale Browne, J. Dale Browne, Cristina M. Furdui, Cristina M. Furdui

    Diterbitkan 2022-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Study protocol: phase II study to evaluate the effect of cetuximab monotherapy after immunotherapy with PD-1 inhibitors in patients with head and neck squamous cell cancer

    Study protocol: phase II study to evaluate the effect of cetuximab monotherapy after immunotherapy with PD-1 inhibitors in patients with head and neck squamous cell cancer oleh Kimberly M. Burcher, Chance H. Bloomer, Elena Gavrila, John M. Kalada, Mark J. Chang, Rediet R. Gebeyehu, Alexander H. Song, Lara M. Khoury, Thomas W. Lycan, Rebecca Kinney, Ralph D’Agostino, Paul M. Bunch, Kirtikar Shukla, Pierre Triozzi, Cristina M. Furdui, Wei Zhang, Mercedes Porosnicu

    Diterbitkan 2024-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    SMARCA4 mutations in KRAS‐mutant lung adenocarcinoma: a multi‐cohort analysis

    SMARCA4 mutations in KRAS‐mutant lung adenocarcinoma: a multi‐cohort analysis oleh Liang Liu, Tamjeed Ahmed, William J. Petty, Stefan Grant, Jimmy Ruiz, Thomas W. Lycan, Umit Topaloglu, Ping‐Chieh Chou, Lance D. Miller, Gregory A. Hawkins, Martha A. Alexander‐Miller, Stacey S. O’Neill, Bayard L. Powell, Ralph B. D’Agostino Jr., Reginald F. Munden, Boris Pasche, Wei Zhang

    Diterbitkan 2021-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Genomic signature for oligometastatic disease in non-small cell lung cancer patients with brain metastases

    Genomic signature for oligometastatic disease in non-small cell lung cancer patients with brain metastases oleh Ariel R. Choi, Ralph B. D’Agostino, Michael K. Farris, Mohammed Abdulhaleem, John C. Hunting, Yuezhu Wang, Margaret R. Smith, Jimmy Ruiz, Thomas W. Lycan, W. Jeffrey Petty, Christina K. Cramer, Stephen B. Tatter, Adrian W. Laxton, Jaclyn J. White, Wencheng Li, Jing Su, Christopher Whitlow, Fei Xing, Michael D. Chan

    Diterbitkan 2024-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: